美股A股
StockGist
Back
8-K2026-03-10· grok-4-1-fast-non-reasoning

CGEM · Cullinan Therapeutics, Inc.

0001193125-26-099355

SEC filing

Summary

Cullinan Therapeutics, Inc. furnished a press release as Exhibit 99.1 under Items 2.02 and 9.01 of Form 8-K on March 10, 2026, pertaining to results of operations. The press release content is not provided in the filing excerpt.

Key takeaways